Robert Iannone

6.0k total citations · 1 hit paper
43 papers, 2.1k citations indexed

About

Robert Iannone is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Robert Iannone has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Hematology and 10 papers in Immunology. Recurrent topics in Robert Iannone's work include Hematopoietic Stem Cell Transplantation (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and CAR-T cell therapy research (5 papers). Robert Iannone is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and CAR-T cell therapy research (5 papers). Robert Iannone collaborates with scholars based in United States, United Kingdom and France. Robert Iannone's co-authors include Ephraim J. Fuchs, Laura Engstrom, Leo Luznik, Sanju Jalla, Sara M. Tolaney, Rebecca Moroose, Aditya Bardia, David M. Goldenberg, Vandana G. Abramson and Robert M. Sharkey and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Robert Iannone

41 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

2019 599 citations Robert Iannone et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Iannone United States	20	980	669	587	391	312	43	2.1k
Eugenio Gallo Italy	27	548 0.6×	711 1.1×	489 0.8×	687 1.8×	165 0.5×	94	2.3k
W. Hiddemann Germany	25	633 0.6×	758 1.1×	248 0.4×	731 1.9×	188 0.6×	100	2.0k
Stefan Früehauf Germany	31	1.0k 1.0×	1.6k 2.4×	553 0.9×	1.1k 2.8×	147 0.5×	119	3.1k
Steven C. Goldstein United States	24	620 0.6×	1.2k 1.8×	647 1.1×	246 0.6×	113 0.4×	84	2.0k
Valerie I. Brown United States	21	515 0.5×	333 0.5×	298 0.5×	727 1.9×	70 0.2×	44	1.5k
Matthew J. Wieduwilt United States	17	572 0.6×	480 0.7×	130 0.2×	726 1.9×	184 0.6×	71	1.8k
Edgar Jost Germany	23	392 0.4×	551 0.8×	314 0.5×	1.0k 2.6×	147 0.5×	100	1.8k
Hiroyuki Fujisaki Japan	24	1.0k 1.0×	603 0.9×	1.3k 2.2×	725 1.9×	169 0.5×	74	2.8k
Massimiliano Bonifacio Italy	23	802 0.8×	979 1.5×	552 0.9×	345 0.9×	55 0.2×	88	2.2k
Martin Moorhead United States	18	389 0.4×	383 0.6×	283 0.5×	577 1.5×	129 0.4×	31	1.8k

Countries citing papers authored by Robert Iannone

Since Specialization

Citations

This map shows the geographic impact of Robert Iannone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Iannone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Iannone more than expected).

Fields of papers citing papers by Robert Iannone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Iannone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Iannone. The network helps show where Robert Iannone may publish in the future.

Co-authorship network of co-authors of Robert Iannone

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Iannone. A scholar is included among the top collaborators of Robert Iannone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Iannone. Robert Iannone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Girgis, Suzette, Kedar S. Vaidya, Funda Meric‐Bernstam, et al.. (2025). Zanidatamab dose optimization in patients with HER2-positive biliary tract cancer (BTC).. Journal of Clinical Oncology. 43(4_suppl). 546–546.

Maese, Luke, Mignon L. Loh, Mi Rim Choi, et al.. (2024). Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children’s Oncology Group AALL1931 study. Blood Advances. 9(1). 66–77.

Davies, Stella M., Robert Iannone, Todd A. Alonzo, et al.. (2019). A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study. Biology of Blood and Marrow Transplantation. 26(4). 712–717. 7 indexed citations

Frappaz, Didier, Sara M. Federico, Andrew D.J. Pearson, et al.. (2016). Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours. European Journal of Cancer. 62. 9–17. 21 indexed citations

Zhao, Yanan, Padmaja Paderu, Radha Railkar, et al.. (2016). BloodAspergillusRNA is a promising alternative biomarker for invasive aspergillosis. Medical Mycology. 54(8). 801–807. 9 indexed citations

Neofytos, Dionysios, Radha Railkar, Kathleen M. Mullane, et al.. (2015). Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis. PLoS ONE. 10(6). e0129022–e0129022. 44 indexed citations

Rockall, Andrea, Norbert Avril, Raymond W. Lam, et al.. (2014). Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test–Retest Measurements for Tumor FDG Uptake, Diameter, and Volume. Clinical Cancer Research. 20(10). 2751–2760. 36 indexed citations

Bohórquez, Sandra Sanabria, David Mozley, Donald Burns, et al.. (2013). ¹¹C-MK-8278 PET as a Tool for Pharmacodynamic Brain Occupancy of Histamine 3 Receptor Inverse Agonists. Journal of Nuclear Medicine. 55(1). 65–72. 20 indexed citations

McLean, Mary A., Amy Sun, Thomas E. Bradstreet, et al.. (2012). Repeatability of edited lactate and other metabolites in astrocytoma at 3T. Journal of Magnetic Resonance Imaging. 36(2). 468–475. 9 indexed citations

10.

Cooper, Todd M., Janet Franklin, Robert B. Gerbing, et al.. (2011). AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia. Cancer. 118(3). 761–769. 136 indexed citations

11.

Iannone, Robert, John Palcza, John J. Renger, et al.. (2011). Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers. Psychopharmacology. 215(4). 643–653. 33 indexed citations

12.

Franklin, Janet, Todd A. Alonzo, Craig A. Hurwitz, et al.. (2008). COG AAML03P1: Efficacy and Safety in a Pilot Study of Intensive Chemotherapy Including Gemtuzumab in Children Newly Diagnosed with Acute Myeloid Leukemia (AML). Blood. 112(11). 136–136. 16 indexed citations

13.

Pulsipher, Michael A., Arnon Nagler, Robert Iannone, & Robert M. Nelson. (2006). Weighing the risks of G‐CSF administration, leukopheresis, and standard marrow harvest: Ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatric Blood & Cancer. 46(4). 422–433. 73 indexed citations

14.

Iannone, Robert, Kwaku Ohene‐Frempong, Ephraim J. Fuchs, James F. Casella, & Allen Chen. (2004). Bone marrow transplantation for sickle cell anemia: Progress and prospects. Pediatric Blood & Cancer. 44(5). 436–440. 18 indexed citations

15.

Shankar, Sadhna, et al.. (2004). Pulmonary Hypertension Complicating Bone Marrow Transplantation for Idiopathic Myelofibrosis. Journal of Pediatric Hematology/Oncology. 26(6). 393–397. 18 indexed citations

16.

Poncz, Mortimer, et al.. (2003). Hematology Grants Workshop. Hematology. 2003(1). 590–596. 1 indexed citations

17.

Iannone, Robert, James F. Casella, Ephraim J. Fuchs, et al.. (2003). Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia. Biology of Blood and Marrow Transplantation. 9(8). 519–528. 209 indexed citations

18.

Luznik, Leo, Laura Engstrom, Robert Iannone, & Ephraim J. Fuchs. (2002). Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation. Biology of Blood and Marrow Transplantation. 8(3). 131–138. 86 indexed citations

19.

Siberry, George K. & Robert Iannone. (2000). The Harriet Lane handbook : a manual for pediatric house officers. Mosby eBooks. 27 indexed citations

20.

Sherman, Michael P., Pamela Rodgers‐Johnson, Owen Morgan, et al.. (1995). Identification of human t cell leukemia/lymphoma virus type i antibodies, dna, and protein in patients with polymyositis. Arthritis & Rheumatism. 38(5). 690–698. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact